Spero Therapeutics (SPRO)
(Delayed Data from NSDQ)
$1.46 USD
+0.03 (2.10%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.47 +0.01 (0.68%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Price, Consensus and EPS Surprise
SPRO 1.46 +0.03(2.10%)
Will SPRO be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SPRO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SPRO
Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates
Will Zimmer Biomet (ZBH) Beat Estimates This Earnings Season?
SPRO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Penumbra (PEN) to Report Q3 Earnings: What's in the Cards?
What's in Store for Boston Scientific (BSX) in Q3 Earnings?
What's in Store for Edwards Lifesciences (EW) in Q3 Earnings?
Other News for SPRO
Spero Therapeutics Delivers On Game Plan To Create Shareholder Value
Spero Therapeutics’ Robust Drug Pipeline and Positive Trial Advancements Prompt Buy Rating
Spero Therapeutics files $300M mixed securities shelf
Spero Therapeutics files $300M mixed securities shelf
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session